Nature Climate Change, Published online: 04 March 2025; doi:10.1038/s41558-024-02197-7

Children will bear considerable burdens of climate change, particularly where impacts intersect with pre-existing vulnerabilities. In this Perspective, the authors highlight how climate factors and socio-political stratifiers increase children’s risks in Africa and propose action to break vulnerability cycles.

When Louis DeRidder was 12 years old, he had a medical emergency that nearly cost him his life. The terrifying experience gave him a close-up look at medical care and made him eager to learn more.

“You can’t always pinpoint exactly what gets you interested in something, but that was a transformative moment,” says DeRidder.

In high school, he grabbed the chance to participate in a medicine-focused program, spending about half of his days during his senior year in high school learning about medical science and shadowing doctors.

DeRidder was hooked. He became fascinated by the technologies that make treatments possible and was particularly interested in how drugs are delivered to the brain, a curiosity that sparked a lifelong passion.

“Here I was, a 17-year-old in high school, and a decade later, that problem still fascinates me,” he says. “That’s what eventually got me into the drug delivery field.”

DeRidder’s interests led him to transfer half-way through his undergraduate studies to Johns Hopkins University, where he performed research he had proposed in a Goldwater Scholarship proposal. The research focused on the development of a nanoparticle-drug conjugate to deliver a drug to brain cells in order to transform them from a pro-inflammatory to an anti-inflammatory phenotype. Such a technology could be valuable in the treatment of neurodegenerative diseases, including Alzheimer’s and Parkinson’s.

In 2019, DeRidder entered the joint Harvard-MIT Health Sciences and Technology program, where he has embarked on a somewhat different type of drug delivery project — developing a device that measures the concentration of a chemotherapy drug in the blood while it is being administered and adjusts the infusion rate so the concentration is optimal for the patient. The system is known as CLAUDIA, or Closed-Loop AUtomated Drug Infusion RegulAtor, and can allow for the personalization of drug dosing for a variety of different drugs.

The project stemmed from discussions with his faculty advisors — Robert Langer, the David H. Koch Institute Professor, and Giovanni Traverso, the Karl Van Tassel Career Development Professor and a gastroenterologist at Brigham and Women’s Hospital. They explained to him that chemotherapy dosing is based on a formula developed in 1916 that estimates a patient’s body surface area. The formula doesn’t consider important influences such as differences in body composition and metabolism, or circadian fluctuations that can affect how a drug interacts with a patient.

“Once my advisors presented the reality of how chemotherapies are dosed,” DeRidder says, “I thought, ‘This is insane. How is this the clinical reality?’”

He and his advisors agreed this was a great project for his PhD.

“After they gave me the problem statement, we began to brainstorm ways that we could develop a medical device to improve the lives of patients” DeRidder says, adding, “I love starting with a blank piece of paper and then brainstorming to work out the best solution.”

Almost from the start, DeRidder’s research process involved MATLAB and Simulink, developed by the mathematical computer software company MathWorks.

“MathWorks and Simulink are key to what we do,” DeRidder says. “They enable us to model the drug pharmacokinetics — how the body distributes and metabolizes the drug. We also model the components of our system with their software. That was especially critical for us in the very early days, because it let us know whether it was even possible to control the concentration of the drug. And since then, we’ve continuously improved the control algorithm, using these simulations. You simulate hundreds of different experiments before performing any experiments in the lab.”

With his innovative use of the MATLAB and Simulink tools, DeRidder was awarded MathWorks fellowships both last year and this year. He has also received a National Science Foundation Graduate Research Fellowship.

“The fellowships have been critical to our development of the CLAUDIA drug-delivery system,” DeRidder says, adding that he has “had the pleasure of working with a great team of students and researchers in the lab.”

He says he would like to move CLAUDIA toward clinical use, where he thinks it could have significant impact. “Whatever I can do to help push it toward the clinic, including potentially helping to start a company to help commercialize the system, I’m definitely interested in doing it.”

In addition to developing CLAUDIA, DeRidder is working on developing new nanoparticles to deliver therapeutic nucleic acids. The project involves synthesizing new nucleic acid molecules, as well as developing the new polymeric and lipid nanoparticles to deliver the nucleic acids to targeted tissue and cells.

DeRidder says he likes working on technologies at different scales, from medical devices to molecules — all with the potential to improve the practice of medicine.

Meanwhile, he finds time in his busy schedule to do community service. For the past three years, he has spent time helping the homeless on Boston streets.

“It’s easy to lose track of the concrete, simple ways that we can serve our communities when we’re doing research,” DeRidder says, “which is why I have often sought out ways to serve people I come across every day, whether it is a student I mentor in lab, serving the homeless, or helping out the stranger you meet in the store who is having a bad day.”

Ultimately, DeRidder says, he’ll head back to work that also recalls his early exposure to the medical field in high school, where he interacted with a lot of people with different types of dementia and other neurological diseases at a local nursing home.

“My long-term plan includes working on developing devices and molecular therapies to treat neurological diseases, in addition to continuing to work on cancer,” he says. “Really, I’d say that early experience had a big impact on me.”

On Feb. 14, some of the nation’s most talented high school researchers convened in Boston for the annual American Junior Academy of Science (AJAS) conference, held alongside the American Association for the Advancement of Science (AAAS) annual meeting. As a highlight of the event, MIT once again hosted its renowned “Breakfast with Scientists,” offering students a unique opportunity to connect with leading scientific minds from around the world.

The AJAS conference began with an opening reception at the MIT Schwarzman College of Computing, where professor of biology and chemistry Catherine Drennan delivered the keynote address, welcoming 162 high school students from 21 states. Delegates were selected through state Academy of Science competitions, earning the chance to share their work and connect with peers and professionals in science, technology, engineering, and mathematics (STEM).

Over breakfast, students engaged with distinguished scientists, including MIT faculty, Nobel laureates, and industry leaders, discussing research, career paths, and the broader impact of scientific discovery.

Amy Keating, MIT biology department head, sat at a table with students ranging from high school juniors to college sophomores. The group engaged in an open discussion about life as a scientist at a leading institution like MIT. One student expressed concern about the competitive nature of innovative research environments, prompting Keating to reassure them, saying, “MIT has a collaborative philosophy rather than a competitive one.”

At another table, Nobel laureate and former MIT postdoc Gary Ruvkun shared a lighthearted moment with students, laughing at a TikTok video they had created to explain their science fair project. The interaction reflected the innate curiosity and excitement that drives discovery at all stages of a scientific career.

Donna Gerardi, executive director of the National Association of Academies of Science, highlighted the significance of the AJAS program. “These students are not just competing in science fairs; they are becoming part of a larger scientific community. The connections they make here can shape their careers and future contributions to science.”

Alongside the breakfast, AJAS delegates participated in a variety of enriching experiences, including laboratory tours, conference sessions, and hands-on research activities.

“I am so excited to be able to discuss my research with experts and get some guidance on the next steps in my academic trajectory,” said Andrew Wesel, a delegate from California.

A defining feature of the AJAS experience was its emphasis on mentorship and collaboration rather than competition. Delegates were officially inducted as lifetime Fellows of the American Junior Academy of Science at the conclusion of the conference, joining a distinguished network of scientists and researchers.

Sponsored by the MIT School of Science and School of Engineering, the breakfast underscored MIT’s longstanding commitment to fostering young scientific talent. Faculty and researchers took the opportunity to encourage students to pursue careers in STEM fields, providing insights into the pathways available to them.

“It was a joy to spend time with such passionate students,” says Kristala Prather, head of the Department of Chemical Engineering at MIT. “One of the brightest moments for me was sitting next to a young woman who will be joining MIT in the fall — I just have to convince her to study ChemE!”

MIT Professor Markus J. Buehler has been named the recipient of the 2025 Washington Award, one of the nation’s oldest and most esteemed engineering honors. 

The Washington Award is conferred to “an engineer(s) whose professional attainments have preeminently advanced the welfare of humankind,” recognizing those who have made a profound impact on society through engineering innovation. Past recipients of this award include influential figures such as Herbert Hoover, the award’s inaugural recipient in 1919, as well as Orville Wright, Henry Ford, Neil Armstrong, John Bardeen, and renowned MIT affiliates Vannevar Bush, Robert Langer, and software engineer Margaret Hamilton.

Buehler was selected for his “groundbreaking accomplishments in computational modeling and mechanics of biological materials, and his contributions to engineering education and leadership in academia.” Buehler has authored over 500 peer-reviewed publications, pioneering the atomic-level properties and structures of biomaterials such as silk, elastin, and collagen, utilizing computational modeling to characterize, design, and create sustainable materials with features spanning from the nano- to the macro- scale. Buehler was the first to explain how hydrogen bonds, molecular confinement, and hierarchical architectures govern the mechanics of biological materials via the development of a theory that bridges molecular interactions with macroscale properties.

His innovative research includes the development of physics-aware artificial intelligence methods that integrate computational mechanics, bioinformatics, and generative AI to explore universal design principles of biological and bioinspired materials. His work has advanced the understanding of hierarchical structures in nature, revealing the mechanics by which complex biomaterials achieve remarkable strength, flexibility, and resilience through molecular interactions across scales.

Buehler's research included the use of deep learning models to predict and generate new protein structures, self-assembling peptides, and sustainable biomimetic materials. His work on materiomusic — converting molecular structures into musical compositions — has provided new insights into the hidden patterns within biological systems.

Buehler is the Jerry McAfee (1940) Professor in Engineering in the departments of Civil and Environmental Engineering (CEE) and Mechanical Engineering. He served as the department head of CEE from 2013 to 2020, as well as in other leadership roles, including as president of the Society of Engineering Science.

A dedicated educator, Buehler has played a vital role in mentoring future engineers, leading K-12 STEM summer camps to inspire the next generation and serving as an instructor for MIT Professional Education summer courses.

His achievements have been recognized with numerous prestigious honors, including the Feynman Prize, the Drucker Medal, the Leonardo da Vinci Award, and the J.R. Rice Medal, and election to the National Academy of Engineering. His work continues to push the boundaries of computational science, materials engineering, and biomimetic design.

The Washington Award was presented during National Engineers Week in February, in a ceremony attended by members of prominent engineering societies, including the Western Society of Engineers; the American Institute of Mining, Metallurgical and Petroleum Engineers; the American Society of Civil Engineers; the American Society of Mechanical Engineers; the Institute of Electrical and Electronics Engineers; the National Society of Professional Engineers; and the American Nuclear Society. The event also celebrated nearly 100 pre-college students recognized for their achievements in regional STEM competitions, highlighting the next generation of engineering talent.

In biology, seeing can lead to understanding, and researchers in Professor Edward Boyden’s lab at the McGovern Institute for Brain Research are committed to bringing life into sharper focus. With a pair of new methods, they are expanding the capabilities of expansion microscopy — a high-resolution imaging technique the group introduced in 2015 — so researchers everywhere can see more when they look at cells and tissues under a light microscope.

“We want to see everything, so we’re always trying to improve it,” says Boyden, the Y. Eva Tan Professor in Neurotechnology at MIT. “A snapshot of all life, down to its fundamental building blocks, is really the goal.” Boyden is also a Howard Hughes Medical Institute investigator and a member of the Yang Tan Collective at MIT. 

With new ways of staining their samples and processing images, users of expansion microscopy can now see vivid outlines of the shapes of cells in their images and pinpoint the locations of many different proteins inside a single tissue sample with resolution that far exceeds that of conventional light microscopy. These advances, both reported in open-access form in the journal Nature Communications, enable new ways of tracing the slender projections of neurons and visualizing spatial relationships between molecules that contribute to health and disease.

Expansion microscopy uses a water-absorbing hydrogel to physically expand biological tissues. After a tissue sample has been permeated by the hydrogel, it is hydrated. The hydrogel swells as it absorbs water, preserving the relative locations of molecules in the tissue as it gently pulls them away from one another. As a result, crowded cellular components appear separate and distinct when the expanded tissue is viewed under a light microscope. The approach, which can be performed using standard laboratory equipment, has made super-resolution imaging accessible to most research teams.

Since first developing expansion microscopy, Boyden and his team have continued to enhance the method — increasing its resolution, simplifying the procedure, devising new features, and integrating it with other tools.

Visualizing cell membranes

One of the team’s latest advances is a method called ultrastructural membrane expansion microscopy (umExM), which they described in the Feb. 12 issue of Nature Communications. With it, biologists can use expansion microscopy to visualize the thin membranes that form the boundaries of cells and enclose the organelles inside them. These membranes, built mostly of molecules called lipids, have been notoriously difficult to densely label in intact tissues for imaging with light microscopy. Now, researchers can use umExM to study cellular ultrastructure and organization within tissues.

Tay Shin SM ’20, PhD ’23, a former graduate student in Boyden’s lab and a J. Douglas Tan Fellow in the Tan-Yang Center for Autism Research at MIT, led the development of umExM. “Our goal was very simple at first: Let’s label membranes in intact tissue, much like how an electron microscope uses osmium tetroxide to label membranes to visualize the membranes in tissue,” he says. “It turns out that it’s extremely hard to achieve this.”

The team first needed to design a label that would make the membranes in tissue samples visible under a light microscope. “We almost had to start from scratch,” Shin says. “We really had to think about the fundamental characteristics of the probe that is going to label the plasma membrane, and then think about how to incorporate them into expansion microscopy.” That meant engineering a molecule that would associate with the lipids that make up the membrane and link it to both the hydrogel used to expand the tissue sample and a fluorescent molecule for visibility.

After optimizing the expansion microscopy protocol for membrane visualization and extensively testing and improving potential probes, Shin found success one late night in the lab. He placed an expanded tissue sample on a microscope and saw sharp outlines of cells.

Because of the high resolution enabled by expansion, the method allowed Boyden’s team to identify even the tiny dendrites that protrude from neurons and clearly see the long extensions of their slender axons. That kind of clarity could help researchers follow individual neurons’ paths within the densely interconnected networks of the brain, the researchers say.

Boyden calls tracing these neural processes “a top priority of our time in brain science.” Such tracing has traditionally relied heavily on electron microscopy, which requires specialized skills and expensive equipment. Shin says that because expansion microscopy uses a standard light microscope, it is far more accessible to laboratories worldwide.

Shin and Boyden point out that users of expansion microscopy can learn even more about their samples when they pair the new ability to reveal lipid membranes with fluorescent labels that show where specific proteins are located. “That’s important, because proteins do a lot of the work of the cell, but you want to know where they are with respect to the cell’s structure,” Boyden says.

One sample, many proteins

To that end, researchers no longer have to choose just a few proteins to see when they use expansion microscopy. With a new method called multiplexed expansion revealing (multiExR), users can now label and see more than 20 different proteins in a single sample. Biologists can use the method to visualize sets of proteins, see how they are organized with respect to one another, and generate new hypotheses about how they might interact.

A key to that new method, reported Nov. 9, 2024, in Nature Communications, is the ability to repeatedly link fluorescently labeled antibodies to specific proteins in an expanded tissue sample, image them, then strip these away and use a new set of antibodies to reveal a new set of proteins. Postdoc Jinyoung Kang fine-tuned each step of this process, assuring tissue samples stayed intact and the labeled proteins produced bright signals in each round of imaging.

After capturing many images of a single sample, Boyden’s team faced another challenge: how to ensure those images were in perfect alignment so they could be overlaid with one another, producing a final picture that showed the precise positions of all of the proteins that had been labeled and visualized one by one.

Expansion microscopy lets biologists visualize some of cells’ tiniest features — but to find the same features over and over again during multiple rounds of imaging, Boyden’s team first needed to home in on a larger structure. “These fields of view are really tiny, and you’re trying to find this really tiny field of view in a gel that’s actually become quite large once you’ve expanded it,” explains Margaret Schroeder, a graduate student in Boyden’s lab who, with Kang, led the development of multiExR.

To navigate to the right spot every time, the team decided to label the blood vessels that pass through each tissue sample and use these as a guide. To enable precise alignment, certain fine details also needed to consistently appear in every image; for this, the team labeled several structural proteins. With these reference points and customized imaging processing software, the team was able to integrate all of their images of a sample into one, revealing how proteins that had been visualized separately were arranged relative to one another.

The team used multiExR to look at amyloid plaques — the aberrant protein clusters that notoriously develop in brains affected by Alzheimer’s disease. “We could look inside those amyloid plaques and ask, what’s inside of them? And because we can stain for many different proteins, we could do a high-throughput exploration,” Boyden says. The team chose 23 different proteins to view in their images. The approach revealed some surprises, such as the presence of certain neurotransmitter receptors (AMPARs). “Here’s one of the most famous receptors in all of neuroscience, and there it is, hiding out in one of the most famous molecular hallmarks of pathology in neuroscience,” says Boyden. It’s unclear what role, if any, the receptors play in Alzheimer’s disease — but the finding illustrates how the ability to see more inside cells can expose unexpected aspects of biology and raise new questions for research.

Funding for this work came from MIT, Lisa Yang and Y. Eva Tan, John Doerr, the Open Philanthropy Project, the Howard Hughes Medical Institute, the U.S. Army, Cancer Research U.K., the New York Stem Cell Foundation, the U.S. National Institutes of Health, Lore McGovern, Good Ventures, Schmidt Futures, Samsung, MathWorks, the Collamore-Rogers Fellowship, the U.S. National Science Foundation, Alana Foundation USA, the Halis Family Foundation, Lester A. Gimpelson, Donald and Glenda Mattes, David B. Emmes, Thomas A. Stocky, Avni U. Shah, Kathleen Octavio, Good Ventures/Open Philanthropy, and the European Union’s Horizon 2020 program.

The 2025 Times Higher Education World University Ranking has ranked MIT first in three subject categories: Arts and Humanities, Business and Economics, and Social Sciences. 

The Times Higher Education World University Ranking is an annual publication of university rankings by Times Higher Education, a leading British education magazine. The subject rankings are based on 18 rigorous performance indicators. Criteria include teaching, research environment, research volume and influence, industry, and international outlook.

Disciplines included in the 2025 top-ranked subjects are housed in the School of Humanities, Arts, and Social Sciences (SHASS), the School of Architecture and Planning (SA+P), and the MIT Sloan School of Management.

“The rankings are a testament to the extraordinary quality of the research and teaching that takes place in SHASS and across MIT,” says Agustín Rayo, Kenan Sahin Dean of SHASS and professor of philosophy. “There has never been a more important time to ensure that we train students who understand the social, economic, political, and human aspects of the great challenges of our time.”

The Arts and Humanities ranking evaluated 750 universities from 72 countries in the disciplines of languages, literature, and linguistics; history, philosophy, and theology; architecture; archaeology; and art, performing arts, and design. This marks the first time MIT has earned the top spot in this subject since Times Higher Education began publishing rankings in 2011.

The ranking for Business and Economics evaluated 990 institutions from 85 countries and territories across three core disciplines: business and management; accounting and finance; and, economics and econometrics. This is the fourth consecutive year MIT has been ranked first in this subject.

The Social Sciences ranking evaluated 1,093 institutions from 100 countries and territories in the disciplines of political science and international studies; sociology, geography, communication and media studies; and anthropology. The areas under evaluation include political science and international relations; sociology; geography; communication and media studies; and anthropology. MIT claimed the top spot alone in this subject, after tying for first in 2024 with Stanford University.

In other subjects, MIT was also named among the top universities, ranking third in Computer Science, Engineering, and Life Sciences, and fourth in Physical Sciences. Overall, MIT ranked second in the Times Higher Education 2025 World University Ranking.

An MIT startup’s personalized heart implants, designed to help prevent strokes, won this year’s MIT Sloan Healthcare Innovation Prize (SHIP) on Thursday.

Spheric Bio’s implants grow inside the body once injected, to fit within the patient’s unique anatomy. This could improve stroke prevention because existing implants are one-size-fits-all devices that can fail to fully block the most at-risk regions, leading to leakages and other complications.

“Our mission is to transform stroke prevention by building personalized medical devices directly inside patients’ hearts,” said Connor Verheyen PhD ’23, a postdoc in the Harvard-MIT Program in Health Sciences and Technology (HST), who made the winning pitch.

Verheyen’s co-founders are MIT Associate Professor Ellen Roche and HST postdoc Markus Horvath PhD ’22.

Spheric Bio was one of seven teams that pitched their solution at the event, which was held in the MIT Media Lab and kicked off the MIT Sloan Healthcare and BioInnovations Conference.

Spheric took home the event’s $25,000 first-place prize. The second-place prize went to nurtur, another MIT alumnus-founded startup, that has developed an artificial intelligence-powered platform designed to detect and prevent postpartum depression. Last summer, nurtur participated in the delta v startup accelerator program organized by the Martin Trust Center for MIT Entrepreneurship.

The audience choice award was given to Merunova, which is using AI and MRI diagnostics to improve the diagnosis and treatment of spinal cord disorders. Merunova was co-founded by Dheera Ananthakrishnan, a former spine surgeon who completed an executive MBA from the MIT Sloan School of Management in 2023.

Personalized stroke prevention

Spheric Bio’s first implants aim to solve the problem of atrial fibrillation, a condition that causes areas of the heart to beat irregularly and rapidly, leading to a dramatic increase in stroke risk. The problem begins when blood pools and clots in the heart. Those clots then move to the brain and cause a stroke.

“This is a problem I’ve witnessed firsthand in my family,” says Verheyen. “It’s so common that millions of families around the world have had to experience a loved one go through a stroke as well.”

Patients with atrial fibrillation today can either go on blood thinners, in many cases for years or even life, or undergo a procedure in which surgeons insert a device into the heart to close off an area known as the left atrial appendage, where about 90 percent of such originate.

The implants on the market today for that procedure are typically prefabricated metal devices that don’t account for the wide variations seen in patient heart anatomy. Verheyen says up to half of the devices fail to seal the appendage. They can also lead to complications and complex care pathways designed to manage those shortcomings.

“There’s a fundamental mismatch between the devices available and what human patients actually look like,” says Verheyen. “Humans are infinitely variable in shape and size, and these tissues in particular are really soft, complex, delicate tissues. It leaves you with a pretty profound incompatibility.”

Spheric Bio’s implants are designed to conform to a patient’s anatomy like water filling a glass. The implant is made of biomaterials developed over years of research at MIT. They are delivered through a catheter and then expand and self-heal to custom fit the patient.

“This gives us complete closure of the appendage for every patient, every time,” said Verheyen, who has successfully tested the device in animals. “It also allows us to reduce device-related complications and simplifies deployment for operators.”

Verheyen conducted his PhD work on medical imaging and medical physics in Roche’s lab. Roche is also the associate head of Department of Mechanical Engineering at MIT.

Innovations for impact

The 23rd annual pitch competition offered anyone interested in health care innovation a look at the promising new solutions being developed at universities. The event is open to all early-stage health care startups with at least one student or recent graduate co-founder.

The event was the result of a months-long process in which more than 100 applicants were whittled down over the course of three rounds by a group of 20 judges.

The final competition also kicked off the MIT Sloan Healthcare and BioInnovations Conference, which took place Feb. 27 and 28. This year’s conference was titled From Innovation to Impact: The Changing Face of Healthcare, and featured keynotes with health care industry veterans including Chris Boerner, the CEO of Bristole Myers Squibb, and James Davis, the CEO of Quest Diagnostics.

The competition’s keynote was delivered by Iterative Health CEO Jonathan Ng, who was a finalist in the competition in 2017. Ng expressed admiration for this year’s contestants.

“It’s inspiring to look around and see people who want to change the world,” said Ng, whose company is using cameras and AI to improve colorectal cancer screening. “There’s a lot of easier industries to work in, but MIT is such a good place to find your tribe: to find people who want to make the same sort of impact on the world as you.”

Stuart Levenbach, who previously served as NOAA’s chief of staff, will join the new administration as an energy official at the Office of Management and Budget.

States are grappling with frozen federal funds and fired feds. “That is how a recession starts,” a Pennsylvania appropriator said.

Iberdrola's CEO offered an optimistic view of a U.S. offshore wind industry that has been rocked by President Donald Trump.

Vermont is too small to run its own market, a new report says. Republican gains in the November election eroded Democrats' power.

The president’s allies say they expect a positive message on energy dominance. Democrats hint they could make their displeasure known.

President Donald Trump and other officials have suggested dismantling the emergency-response agency.

About 8 in 10 Americans say they've experienced extreme weather in recent years, with half saying they've been affected by severe cold or severe winter storms.

The announcement comes as some of the world’s biggest banks recalibrate their approach to climate finance.

The electric induction stove runs on 120 volts, meaning there is no need to pay a licensed electrician to rewire to 240 volts, which many electric stoves require.

Maine’s haul of lobsters has declined every year from 2021, when it was nearly 111 million pounds, to 2024, when the haul was about 86.1 million pounds.

Nature Climate Change, Published online: 03 March 2025; doi:10.1038/s41558-025-02254-9

Side events of annual UNFCCC Conferences of Parties are one of several channels by which non-state actors influence climate negotiation. By analysing discourse and networks of actors, this research examines how topics evolve over time and how energy interest groups gain access to agenda setting.

Nature Climate Change, Published online: 03 March 2025; doi:10.1038/s41558-025-02268-3

Rising wealth inequality is a major challenge for this century, and climate change could further exacerbate it. Based on an overview of existing studies, this Perspective proposes a framework to advance understanding of wealth inequality in relation to climate change and climate policies.

Firefly squid is now a delicacy in New York.

Blog moderation policy.